Clinical Trials Browser

Phase 2 × Camurati-Engelmann Syndrome × ascrinvacumab × Clear all

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Camurati-Engelmann Syndrome, Neoplasm Metastasis, Recurrence